BioMarin Pharmaceutical
BMRN
#1317
Rank
A$21.80 B
Marketcap
$114.30
Share price
-0.20%
Change (1 day)
-14.94%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): A$0.58 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$2.75 Billion. In 2023 the company made an earning of A$0.30 Billion, an increase over its 2022 earnings that were of A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.58 B91.8%
2023 A$0.30 B26.07%
2022 A$0.24 B-298.51%
2021 -A$0.13 Billion78.04%
2020 -A$68.12 Million-55.36%
2019 -A$0.16 Billion-33.56%
2018 -A$0.23 Billion297.78%
2017 -A$57.74 Million-95.68%
2016 -A$1.34 Billion437.12%
2015 -A$0.25 Billion23.91%
2014 -A$0.21 Billion-29.25%
2013 -A$0.29 Billion49.23%
2012 -A$0.2 Billion171.11%
2011 -A$70.22 Million103.01%
2010 -A$34.59 Million-3903.54%
2009 A$0.9 M-98.31%
2008 A$53.79 M-189.7%
2007 -A$59.98 Million51.02%
2006 -A$39.72 Million-61.58%
2005 -A$0.11 Billion-56.59%
2004 -A$0.24 Billion95.13%
2003 -A$0.13 Billion12.09%
2002 -A$0.11 Billion73.19%
2001 -A$62.85 Million18.32%
2000 -A$53.12 Million19.65%
1999 -A$44.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.82 Billion-228.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.22 Billion-134.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$46.49 Million-107.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.78 B 1,928.87%๐Ÿ‡ซ๐Ÿ‡ท France
-A$46.29 Million-107.35%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.30 B-51.77%๐Ÿ‡บ๐Ÿ‡ธ USA